India's Metropolis Healthcare gains on buying Core Diagnostics

Metropolis Healthcare

10/12/2024 04:14

** Metropolis Healthcare  METP.NS  rises 2.7% to 2,249.70
rupees
    ** Co will acquire 100% stake in oncology testing lab Core
Diagnostics for equity value of 2.47 bln rupees ($29 mln)
    ** Says 45% to be funded by equity swap and 55% by cash
consideration
    ** Stock eyes a three-day rally
    ** METP up ~32% YTD

($1 = 84.7970 Indian rupees)

 (Reporting by Yagnoseni Das in Bengaluru)
 ((Yagnoseni.Das@thomsonreuters.com;))